Fetal growth restriction and neonatal-pediatric lung diseases: Vascular mechanistic links and therapeutic directions
- PMID: 36503648
- DOI: 10.1016/j.prrv.2022.09.002
Fetal growth restriction and neonatal-pediatric lung diseases: Vascular mechanistic links and therapeutic directions
Abstract
Bronchopulmonary dysplasia (BPD) is the most common respiratory sequela of prematurity, and infants born with fetal growth restriction (FGR) are disproportionately represented in BPD statistics, as factors which affect somatic growth may also affect pulmonary growth. Effects of in-utero hypoxia underlying FGR on lung parenchymal architecture predisposing to BPD are well documented, but the pulmonary vascular constructs are not well appreciated. Disruption of angiogenesis during critical periods of lung growth impairs alveolarization, contributing to BPD pathogenesis. Pulmonary artery thickness/stiffness has been noted in FGR in the initial postnatal weeks, and also in well-grown infants with established BPD. The lack of waveform cushioning by the major arteries exposes the pulmonary resistance vessels to higher pulsatile stress, thereby accelerating microvascular disease. Reactive oxygen species, increased sympathetic activity and endothelial dysfunction are common mediators in FGR and BPD; each putative targets for prevention and/or therapeutics using interleukin (IL)-1 receptor antagonist (IL-1Ra), melatonin or inhibition of renin-angiotensin-aldosterone system. While BPD is the archetypal respiratory disease of infancy, effects of FGR on pulmonary function are long-term, extending well into childhood. This narrative links FGR in very/extremely preterm infants with BPD through the vascular affliction as a mechanistic and potentially, therapeutic pathway. Our objectives were to depict the burden of disease for FGR and BPD amongst preterm infants, portray vascular involvement in the placenta in FGR and BPD cohorts, provide high resolution vascular ultrasound information in both cohorts with a view to address therapeutic relevance, and lastly, link this information with paediatric age-group lung diseases.
Keywords: Arterial stiffness; Bronchopulmonary dysplasia; Fetal growth restriction; Mechanisms; Placenta.
Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Fetal Doppler velocimetry and bronchopulmonary dysplasia risk among growth-restricted preterm infants: an observational study.BMJ Open. 2017 Jul 20;7(7):e015232. doi: 10.1136/bmjopen-2016-015232. BMJ Open. 2017. PMID: 28729313 Free PMC article.
-
Preterm growth restriction and bronchopulmonary dysplasia: the vascular hypothesis and related physiology.J Physiol. 2019 Feb;597(4):1209-1220. doi: 10.1113/JP276040. Epub 2018 Jun 13. J Physiol. 2019. PMID: 29746007 Free PMC article.
-
Novel concepts of treating vascular inflammation underlying neonatal lung diseases.J Appl Physiol (1985). 2023 Jul 1;135(1):174-182. doi: 10.1152/japplphysiol.00549.2022. Epub 2023 May 25. J Appl Physiol (1985). 2023. PMID: 37227180
-
Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.Neonatology. 2015;107(4):358-9. doi: 10.1159/000381132. Epub 2015 Jun 5. Neonatology. 2015. PMID: 26044104 Review.
-
An update on the diagnosis and management of bronchopulmonary dysplasia (BPD)-associated pulmonary hypertension.Semin Perinatol. 2018 Nov;42(7):432-443. doi: 10.1053/j.semperi.2018.09.005. Epub 2018 Oct 4. Semin Perinatol. 2018. PMID: 30384985 Review.
Cited by
-
Role of Myeloperoxidase, Oxidative Stress, and Inflammation in Bronchopulmonary Dysplasia.Antioxidants (Basel). 2024 Jul 23;13(8):889. doi: 10.3390/antiox13080889. Antioxidants (Basel). 2024. PMID: 39199135 Free PMC article. Review.
-
Cardiovascular Sequelae of Bronchopulmonary Dysplasia in Preterm Neonates Born before 32 Weeks of Gestational Age: Impact of Associated Pulmonary and Systemic Hypertension.J Cardiovasc Dev Dis. 2024 Jul 26;11(8):233. doi: 10.3390/jcdd11080233. J Cardiovasc Dev Dis. 2024. PMID: 39195141 Free PMC article. Review.
-
Reduced lung function during childhood in identical twins with discordant fetal growth: a cohort study.EClinicalMedicine. 2024 Apr 10;72:102600. doi: 10.1016/j.eclinm.2024.102600. eCollection 2024 Jun. EClinicalMedicine. 2024. PMID: 38633574 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous